Prescribing overview
Pepcid is a human acid-suppressant product. The reviewed label does not establish an approved veterinary dose.
Key prescribing checks
- Review kidney function and concurrent medicines. The prescription label warns about accumulation and adverse effects with significant renal impairment.
- The label contraindicates use with a history of serious hypersensitivity to famotidine or other H2 blockers.
- Acid suppression can affect absorption of some medicines. Reconcile the full medication list, and assess vomiting blood or black stools promptly rather than allowing an OTC identity match to delay diagnosis.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Humans; animal indication not verified
Human prescription labelingSelected acid-related gastrointestinal diseases
An animal indication requires a veterinary prescribing assessment.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Blocks gastric H2 receptors, reducing gastric acid secretion.
Absorption, distribution, metabolism and elimination
Human renal impairment can increase exposure. Human PK values are not presented as animal values.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Pepcid
Human prescription single-ingredient famotidine tablets; human restrictions do not establish animal contraindications.
Contraindications · when not to use
- History of serious hypersensitivity to famotidine or other H2-receptor antagonists.
Precautions & monitoring
- Renal impairment increases CNS adverse-reaction and QT-prolongation risk. Symptom improvement does not exclude gastric malignancy.
Pepcid AC
Human OTC maximum-strength famotidine tablets; human restrictions do not establish animal contraindications.
Contraindications · when not to use
- Allergy to famotidine or other acid reducers; concurrent other acid reducers. Do not self-treat painful/difficult swallowing, bloody vomiting or bloody/black stools.
Precautions & monitoring
- Review kidney disease, persistent symptoms, unexplained weight loss and pregnancy/breastfeeding with a clinician.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
The human label warns of CNS reactions and QT prolongation particularly with renal impairment; animal rates are not established here.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
Veterinary dose not verified; human doses omitted. Pepcid Complete is not plain famotidine.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This is a selected interaction reference, not an automated or comprehensive combination checker. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Pepcid
Human prescription single-ingredient famotidine tablets; human restrictions do not establish animal contraindications.
- Reduced gastric acidity can lower absorption of pH-dependent drugs. Avoid tizanidine combination when possible because exposure and hypotension/bradycardia/sedation can increase.
Pepcid AC
Human OTC maximum-strength famotidine tablets; human restrictions do not establish animal contraindications.
- Prescription medicines require interaction review.
Monitoring
Review kidney function and medicines whose absorption depends on gastric acidity.
Client counseling
Do not use an OTC product identity to delay assessment of bloody vomiting or black stools.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Follow the actual formulation's package instructions.
Brands, formulations & ingredient identity
Active ingredients
Famotidine
Pepcid and Pepcid AC single-ingredient products contain famotidine, with strengths that may differ between prescription and OTC packages.
Pepcid Complete is a combination product with antacids and must not be treated as a synonym for plain famotidine.
Confirm the complete active-ingredient panel, strength and dosage form. The OTC brand name does not establish an appropriate animal formulation or regimen.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Pepcid
- Formulation
- Oral tablets
- Label / product scope
- Human product
Human single-ingredient famotidine product.
Product label / source ↗Pepcid AC
- Formulation
- Oral tablets
- Label / product scope
- Human product
Human OTC famotidine; verify the package strength and distinguish Pepcid Complete.
Product label / source ↗References & review status
Clinical reference updated October 16, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.